DAM
GOSS icon

DLD Asset Management’s Gossamer Bio GOSS Stock Holding History

DLD Asset Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-176,800
Closed -$464K – 413
2025
Q3 		$464K Buy
176,800
+117,200
+197% +$258K 0.03% 224
2025
Q2 		$73K Buy
+59,600
New +$65K 0.01% 232
2019
Q4 		– Sell
-102,000
Closed -$1.71M – 95
2019
Q3 		$1.71M Buy
+102,000
New +$2.03M 0.09% 55

Other funds holding GOSS

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

DLD Asset Management's GOSS Position: Q4 2025 in Review

DLD Asset Management sold out of Gossamer Bio (GOSS) in Q4 2025, closing a stake of 37,543 shares — an estimated $98.7K sold.

DLD Asset Management first reported a position in GOSS in Q3 2025 and held it in 1 quarter. The position peaked at $98.7K in Q3 2025. 195 funds tracked by Wall St. Rank hold GOSS as of Q4 2025.

  • DLD Asset Management reported no remaining Gossamer Bio position as of Q4 2025 after selling out during the quarter.
  • DLD Asset Management sold 37,543 Gossamer Bio shares in Q4 2025, an estimated $98.7K.
  • DLD Asset Management first reported a position in Gossamer Bio in Q3 2025 and held it in 1 quarter.
  • DLD Asset Management's Gossamer Bio position peaked at $98.7K in Q3 2025.
  • 195 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2025.

Based on DLD Asset Management's 13F filing for Q4 2025, filed 13 Feb 2026.